Kodiak Sciences, Inc. (KOD)
40.41
-1.57
(-3.74%)
USD |
NASDAQ |
Apr 16, 16:00
40.41
0.00 (0.00%)
After-Hours: 20:00
Kodiak Sciences Research and Development Expense (Quarterly) : 45.49M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Tango Therapeutics, Inc. | 31.62M |
| Eli Lilly & Co. | 3.802B |
| Catalyst Pharmaceuticals, Inc. | 1.807M |
| Madrigal Pharmaceuticals, Inc. | 115.88M |
| ADMA Biologics, Inc. | 1.376M |